Perinatal Hypoxia Clinical Trial
Official title:
Serum Erythropoietin Level for Detection of Kidney and Brain Injuries in Asphyxiated Neonates in Neonatal Intensive Care Unit.
This study is to evaluate brain and kidney injuries in full-term neonates with perinatal asphyxia by detecting specific biomarker in blood (Erythropoietin).
Perinatal hypoxic-ischemic encephalopathy (HIE) is an important cause of brain injury in the newborn and can result in long-term devastating consequences. Acute kidney injury (AKI) occurs in (50 - 72%) among asphyxiated term infants. The kidney cells that make erythropoietin are sensitive to low oxygen levels in the blood that travels through the kidney. These cells make and release erythropoietin when the oxygen level is too low. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03407729 -
Measuring Brain Activity of School Age Children
|
||
Not yet recruiting |
NCT04913324 -
Early Virtual Intervention for Infants With CP Following HIE Diagnosis
|
N/A |